Eli Lilly is launching LillyDirect to deliver Mounjaro straight to Australian patients’ doors — and local doctors and ...
Congo's Ebola outbreak has killed more than 4,000 people, authorities said, as they struggle to contain what has become the ...
The redesign is intended to streamline what was a sprawling and fractured information ecosystem, requiring users to ...
The small biotech company Invivyd is developing an injectable, low-dose monoclonal antibody to protect against Covid.
Lizzy led STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the FDA, industry influence, and the agency’s ability to protect and promote public health.
News of a fifth measles death in Pennsylvania underscores a longstanding issue about the disease. The full scope of the ...
Ahead of this year's Nobel Prize announcements, STAT chatted with Mary-Claire King, who discovered the BRCA cancer mutations ...
The U.S. approved 10 drugmakers to participate in a 340B pilot program that will allow them to offer rebates, instead of ...
Proposed changes to the federal government’s health survey would undercount Americans with disabilities, advocates say.
Premiums are stable, but Medicare Advantage plans are making big changes that could make care more expensive for patients.
The NIH continued reducing grants involving health disparities, race, and ethnicity but made little progress toward other administration priorities in the 2026 fiscal year.
Senate committees that handle important health care matters are about to see major GOP turnover. Here's what that means.